{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:44:58Z","timestamp":1782747898668,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Pacing and Electrophysiology Journal"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ipej.2026.03.007","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:19:16Z","timestamp":1772583556000},"page":"288-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Left atrial appendage occlusion versus NOACs in atrial fibrillation: Which way is the weight of evidence tilting in 2026?"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1732-3503","authenticated-orcid":false,"given":"Sivaram","family":"Neppala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1608-2675","authenticated-orcid":false,"given":"Adil","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3002-982X","authenticated-orcid":false,"given":"Priyansh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemal M.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ipej.2026.03.007_bib1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ipej.2026.03.007_bib2","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: Peri-procedural outcomes from the EWOLUTION registry","volume":"37","author":"Boersma","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ipej.2026.03.007_bib3","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.jacc.2017.10.085","article-title":"Relationship of aging and incidence of bleeding in patients with atrial fibrillation on anticoagulation","volume":"71","author":"Chao","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2026.03.007_bib4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ipej.2026.03.007_bib5","first-page":"1455","article-title":"Bleeding with anticoagulant therapy in atrial fibrillation","volume":"38","author":"Diener","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ipej.2026.03.007_bib6","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S1474-4422(10)70274-X","article-title":"Dabigatran compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack","volume":"9","author":"Diener","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ipej.2026.03.007_bib7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR left atrial appendage occlusion registry","volume":"75","author":"Freeman","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2026.03.007_bib8","first-page":"723","article-title":"Selecting patients for left atrial appendage occlusion","volume":"145","author":"Freeman","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.03.007_bib9","first-page":"1","article-title":"Temporal trends in complications after left atrial appendage occlusion","volume":"79","author":"Giri","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2026.03.007_bib10","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ipej.2026.03.007_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/europace\/euz258","article-title":"EHRA\/EAPCI expert consensus on catheter-based left atrial appendage occlusion","volume":"22","author":"Glikson","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.ipej.2026.03.007_bib12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ipej.2026.03.007_bib13","first-page":"138","article-title":"Stroke prevention in atrial fibrillation patients with chronic kidney disease","volume":"139","author":"Hart","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.03.007_bib14","first-page":"3297","article-title":"Efficacy of apixaban in patients with atrial fibrillation and prior stroke","volume":"43","author":"Hohnloser","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.ipej.2026.03.007_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the WATCHMAN left atrial appendage closure device versus long-term warfarin therapy","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2026.03.007_bib16","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.jacc.2019.09.064","article-title":"Left atrial appendage occlusion: lessons learned and future directions","volume":"74","author":"Holmes","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2026.03.007_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2023.05.022","article-title":"Rationale and design of a randomized study comparing the WATCHMAN FLX device to direct oral anticoagulants","volume":"264","author":"Kar","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.ipej.2026.03.007_bib18","first-page":"1929","article-title":"Risk profiles and antithrombotic treatment of patients with newly diagnosed atrial fibrillation","volume":"382","author":"Kakkar","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ipej.2026.03.007_bib19","first-page":"1","article-title":"Real-world use of NOACs in Asia","volume":"104","author":"Krittayaphong","year":"2018","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ipej.2026.03.007_bib20","article-title":"Long-term outcomes of randomized controlled trials comparing percutaneous left atrial appendage closure to oral anticoagulation for nonvalvular atrial fibrillation: a meta-analysis","volume":"7","author":"Madhavan","year":"2022","journal-title":"Struct Heart"},{"key":"10.1016\/j.ipej.2026.03.007_bib21","first-page":"1589","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"382","author":"Osmancik","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ipej.2026.03.007_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"Four-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2026.03.007_bib23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ipej.2026.03.007_bib24","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Long-term results of PROTECT AF: the mortality effects of left atrial appendage closure","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2026.03.007_bib25","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous left atrial appendage closure versus warfarin therapy for prevention of stroke","volume":"374","author":"Reddy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ipej.2026.03.007_bib26","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"Five-year outcomes after left atrial appendage closure: PROTECT AF and PREVAIL","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2026.03.007_bib27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ipej.2026.03.007_bib28","first-page":"2878","article-title":"Antithrombotic therapy and device-related thrombosis following left atrial appendage closure","volume":"74","author":"Saw","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2026.03.007_bib29","first-page":"1","article-title":"Comparative effectiveness of direct oral anticoagulants in routine care","volume":"169","author":"Shah","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ipej.2026.03.007_bib30","first-page":"1","article-title":"Assessment of bleeding risk with left atrial appendage closure versus oral anticoagulants","volume":"8","author":"Turagam","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"19","key":"10.1016\/j.ipej.2026.03.007_bib31","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ipej.2026.03.007_bib32","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.121.057859","article-title":"Amulet or watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial","volume":"145","author":"Galea","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ipej.2026.03.007_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jacc.2025.03.535","article-title":"3-Year clinical outcomes comparing the amulet vs watchman FLX for left atrial appendage closure in patients with atrial fibrillation: results from the SWISS-APERO randomized clinical trial","volume":"86","author":"Galea","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ipej.2026.03.007_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013750","article-title":"Outcomes with the WATCHMAN FLX in everyday clinical practice from the NCDR left atrial appendage occlusion registry","volume":"17","author":"Kapadia","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.ipej.2026.03.007_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2022.100136","article-title":"Left atrial appendage occlusion: current advances and remaining challenges","volume":"1","author":"Alkhouli","year":"2022","journal-title":"JACC Adv"},{"issue":"13","key":"10.1016\/j.ipej.2026.03.007_bib36","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ipej.2026.03.007_bib37","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation (OPTION Trial)","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ipej.2026.03.007_bib38","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery","volume":"384","author":"Whitlock","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ipej.2026.03.007_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2026.107367","article-title":"Left atrial appendage occlusion versus NOACs in patients with atrial fibrillation: rationale and design of the CATALYST trial","author":"Reddy","year":"2026","journal-title":"Am Heart J"},{"key":"10.1016\/j.ipej.2026.03.007_bib40","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.ipej.2026.03.007_bib41","first-page":"1","article-title":"LAA closure in the era of NOACs: where do we stand?","volume":"19","author":"Osmancik","year":"2023","journal-title":"EuroIntervention"}],"container-title":["Indian Pacing and Electrophysiology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972629226000719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972629226000719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:56:38Z","timestamp":1782744998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0972629226000719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0972629226000719"],"URL":"https:\/\/doi.org\/10.1016\/j.ipej.2026.03.007","relation":{},"ISSN":["0972-6292"],"issn-type":[{"value":"0972-6292","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left atrial appendage occlusion versus NOACs in atrial fibrillation: Which way is the weight of evidence tilting in 2026?","name":"articletitle","label":"Article Title"},{"value":"Indian Pacing and Electrophysiology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ipej.2026.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian Heart Rhythm Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}